Latest Conference Articles

Study results show that a regimen of three antiretroviral drugs taken during pregnancy significantly reduces the rate of mother-to-child HIV transmission.

Favipiravir, an experimental drug to treat the deadly Ebola virus, appeared to help some patients in Guinea with the disease but not others, according to results of the trial released at the 2015 Conference on Retroviruses and Opportunistic Infections held this week in Seattle.

The Ebola virus epidemic in West Africa led to a decline in the number of people seeking general outpatient services and as a result caused a drop in HIV testing and enrollment of new patients who are HIV positive, a new study suggests.

Clinicians have several options when it comes to treating their allergic patients with subcutaneous (SCIT) or sublingual (SLIT) immunotherapy.

Evidence shows that patients with chronic urticaria have autoimmunity, reduced basophil number and function, and precedent or concurrent infections.

Researchers have been investigating potential mechanisms involved in the generation of urticarial lesions, the role of IgE-targeting in allergic diseases, and the clinical characteristics of chronic spontaneous urticaria.

Adding tiotropium Respimat treatment in adult patients with mild, moderate, and severe asthma who continue to experience symptoms despite the use of maintenance therapies significantly improved lung function, according to a presentation by Boehringer Ingelheim scientists at the 2015 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting in Houston, TX.

Clinicians have several guidelines, algorithms, and other tools at their disposal that can assist them in the differential diagnosis and management of chronic urticaria.

The skin microbiome may have beneficial influence on the skin through three mechanisms: direct inhibition of pathogen growth, improvement of the host's immune system, and education and priming of the adaptive immune system

The incidence of allergic asthma and other airway diseases in childhood has increased in industrialized societies, and it is known that environmental exposures play a role in their development.

Studies show that children exposed to a more diverse microbial environment in early life may have lower risk for allergy, asthma, and other disorders.

Paul V. Williams, MD, chair of the 2015 AAAAI annual meeting planning committee, discusses key presentations and features attendees should watch for at this year's event.

The Society of NeuroInterventional Surgery plans to issue new guidelines for treatment of ischemic stroke, its president-elect said. Donald Frei, MD, a Denver-based neurosurgeon, said that based on the overwhelmingly positive results of 3 studies, intravascular thrombectomy is the best treatment for many patients with major ischemic strokes.

There are new tools being developed everyday to help patients and healthcare professionals diagnose a wide variety of conditions. One recent study looked at the compliance levels achieved by a patch that can be used to help check a patient's heart health.

Unlike other conditions there is no one thing that can be done to fully prevent stroke. Even with the odds stacked against them a group is working to manage the effects of stroke on a worldwide basis.

Once a patient has a stroke how they recover can be determined by several factors. Recently a team of researchers looked at whether genetics could play a role in how different patients function after the event.

Patients who got twice as much rehabilitative care after a stroke did no better than peers who got usual therapy, a multi-center trial called ICARE found.

In the MR CLEAN trials, physicians were to decide whether patients should be immobilized with general anesthesia or given local anesthesia. Presenting another look-back at MR CLEAN trial data at the American Heart Association/American Stroke Association International Stroke Conference in Nashville, Tenn. on Feb. 13, Olvert Berkhemer, MD and colleagues said their center's strong preference is for local anesthesia.

The more endovascular therapy is used in the treatment of stroke patients the more data there will be about its efficacy. Looking at those numbers and determining what they man can be as important as the procedures themselves.

Like most other procedures, endovascular therapy comes with some inherent risks, but when managed correctly it can provide lasting results for stroke patients.

While other endovascular therapies presented at the International Stroke Conference required more specialized imaging to reach their final results the authors of one study showed that more basic work can be just as effective.

As the population continues to age and more and more people are diagnosed with Alzheimer's Disease or some other form of dementia researchers are looking into what can be done to stem the tide of further diagnoses.

It was not long ago that the merits of endovascular therapy were questioned by some in the healthcare field. A recent push and some new tools have given the debate a stronger argument in favor of the procedures.

As more endovascular therapy options are developed doctors will have the chance to learn a variety of methods and decide which will work best for their individual patients.

Patients who come to a hospital following a stroke face a variety of challenges and complications. A recent study looked at a possible treatment for those who suffered only a mild or moderate stroke.

The results of the SWIFT PRIME Trial as well as several others have given hope that endovascular therapy could become a key tool to help treat patients who have suffered a severe stroke.

As one of the key presentations at the International Stroke Conference the results of the SWIFT PRIME study showed that when conducted in the right circumstances the procedure can provide great benefits for stroke patients.

It will take the work of not only healthcare professionals but also government entities to help with stroke management around the world.

Endovascular Therapy has been under significant scrutiny in recent years, but following studies conducted that view could be changing.

As endovascular treatment has come under the microscope in recent years several studies have shown with the right training and equipment it can be a viable option for stroke patients.